Cargando…

Current and Future Considerations for the Treatment of Hospital-Acquired Pneumonia

ABSTRACT: Hospital-acquired pneumonia (HAP) and health-care-associated pneumonia (HCAP) are leading causes of death, morbidity, and resource utilization in hospitalized patients, and are associated with a broad range of Gram-positive and Gram-negative pathogens. Here, we discuss the different defini...

Descripción completa

Detalles Bibliográficos
Autores principales:	Montravers, Philippe, Harpan, Adela, Guivarch, Elise
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769724/ https://www.ncbi.nlm.nih.gov/pubmed/26861846 http://dx.doi.org/10.1007/s12325-016-0293-x

Ejemplares similares

Performance of pre-hospital evaluations in ruling out invasive chest stab wounds
por: Augustin, Pascal, et al.
Publicado: (2020)

Performance and impact of a multiplex PCR in ICU patients with ventilator-associated pneumonia or ventilated hospital-acquired pneumonia
por: Peiffer-Smadja, Nathan, et al.
Publicado: (2020)

Aerosolized antibiotics in the treatment of hospital-acquired pneumonia/ventilator-associated pneumonia
por: Jung, Yun Jung, et al.
Publicado: (2022)

Management of community-acquired bacterial pneumonia in adults: Limitations of current antibiotics and future therapies
por: Nayar, Sandeep, et al.
Publicado: (2019)

Brief summary of French guidelines for the prevention, diagnosis and treatment of hospital-acquired pneumonia in ICU
por: Leone, Marc, et al.
Publicado: (2018)

Teledermatology: current indications and considerations for future use
por: Beer, Jacob, et al.
Publicado: (2020)

The current pathogens and treatment of hospital-acquired pneumonia/ventilator-associated pneumonia in medical intensive care units
por: Chang, Y, et al.
Publicado: (2015)

Hot topics and current controversies in community-acquired pneumonia
por: Severiche-Bueno, Diego, et al.
Publicado: (2019)

Clinical utility of telavancin for treatment of hospital-acquired pneumonia: focus on non-ventilator-associated pneumonia
por: Rubinstein, Ethan, et al.
Publicado: (2014)

Investigational and Experimental Drugs for Community-Acquired Pneumonia: the Current Evidence
por: Sellarès-Nadal, Juilia, et al.
Publicado: (2020)

Advances in the Treatment of Dysphagia in Neurological Disorders: A Review of Current Evidence and Future Considerations
por: Cheng, Ivy, et al.
Publicado: (2022)

Immunotherapy of Head and Neck Cancer: Current and Future Considerations
por: Rapidis, Alexander D., et al.
Publicado: (2009)

Consideration in treatment decisions for refractory Mycoplasma pneumoniae pneumonia
por: Cho, Hye-Kyung
Publicado: (2021)

Q Fever Vaccine Development: Current Strategies and Future Considerations
por: Long, Carrie Mae
Publicado: (2021)

MAP, Johne’s disease and the microbiome; current knowledge and future considerations
por: Matthews, Chloe, et al.
Publicado: (2021)

P24 Auditing antibiotic course lengths for the management of community-acquired pneumonia and hospital-acquired pneumonia against current NICE guidance
por: Chua, Elaine, et al.
Publicado: (2023)

Reference intervals: current status, recent developments and future considerations
por: Ozarda, Yesim
Publicado: (2016)

Targeting Schlemm’s Canal in the Medical Therapy of Glaucoma: Current and Future Considerations
por: Andrés-Guerrero, Vanessa, et al.
Publicado: (2017)

Is ventilated hospital-acquired pneumonia a worse entity than ventilator-associated pneumonia?
por: Vallecoccia, Maria Sole, et al.
Publicado: (2020)

Pathogenesis and Bone Resorption in Acquired Cholesteatoma: Current Knowledge and Future Prospectives
por: Hamed, Mahmood A., et al.
Publicado: (2016)

Treatment of Community-Acquired Pneumonia: A Case Report and Current Treatment Dilemmas
por: Harnett, Glenn
Publicado: (2017)

Linezolid for the treatment of hospital-acquired pneumonia in a Chinese tertiary hospital
por: Lesher, Beth A, et al.
Publicado: (2015)

Mechanistic evaluation of phytochemicals in breast cancer remedy: current understanding and future perspectives
por: Younas, Muhammad, et al.
Publicado: (2018)

Biosimilars in oncology and inflammatory diseases: current and future considerations for clinicians in Latin America
por: Scheinberg, Morton, et al.
Publicado: (2018)

Advances in the prevention, management, and treatment of community-acquired pneumonia
por: Pletz, Mathias W., et al.
Publicado: (2016)

Treatment of community-acquired pneumonia, with special emphasis on gemifloxacin
por: Öncü, Serkan
Publicado: (2007)

Treatment of Community-Acquired Pneumonia: A Focus on Lefamulin
por: Eraikhuemen, Nathaniel, et al.
Publicado: (2021)

Bacterial etiology and mortality rate in community-acquired pneumonia, healthcare-associated pneumonia and hospital-acquired pneumonia in Thai university hospital
por: Poovieng, Jaturon, et al.
Publicado: (2022)

S17.3 PK/PD in the treatment of hospital-acquired pneumonia
Publicado: (2005)

Ten Issues to Update in Nosocomial or Hospital-Acquired Pneumonia: An Expert Review
por: Candel, Francisco Javier, et al.
Publicado: (2023)

Current Status of Community-Acquired Pneumonia in Patients with Chronic Obstructive Pulmonary Disease
por: Liu, De-Shun, et al.
Publicado: (2018)

Comprehensive risk assessment for hospital-acquired pneumonia: sociodemographic, clinical, and hospital environmental factors associated with the incidence of hospital-acquired pneumonia
por: Kim, Bo-Guen, et al.
Publicado: (2022)

Pharmacokinetics and Dosing of Ceftobiprole Medocaril for the Treatment of Hospital- and Community-Acquired Pneumonia in Different Patient Populations
por: Torres, Antonio, et al.
Publicado: (2016)

Narrative Review of the Epidemiology of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia in Gulf Cooperation Council Countries
por: Abdalla, Jehad S., et al.
Publicado: (2023)

Current Concepts of Severe Pneumococcal Community-acquired Pneumonia
por: Luján, M., et al.
Publicado: (2007)

Current Concepts of Severe Pneumococcal Community-acquired Pneumonia
por: Luján, M., et al.
Publicado: (2007)

Advances in community-acquired pneumonia
por: Jones, Barbara, et al.
Publicado: (2020)

Evolving strategies for meningococcal vaccination in Europe: Overview and key determinants for current and future considerations
por: Martinón-Torres, Federico, et al.
Publicado: (2021)

Rice Molecular Breeding Laboratories in the Genomics Era: Current Status and Future Considerations
por: Collard, Bert C. Y., et al.
Publicado: (2008)

Pulmonary Effects of Adjusting Tidal Volume to Actual or Ideal Body Weight in Ventilated Obese Mice
por: Guivarch, Elise, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_dk8prcqgbtrdm0rmf23vt44m9v